Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Depomed Inc (DEPO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 744,579
  • Shares Outstanding, K 62,100
  • Annual Sales, $ 455,900 K
  • Annual Income, $ -88,720 K
  • 36-Month Beta 1.32
  • Price/Sales 1.66
  • Price/Cash Flow 19.53
  • Price/Book 2.98

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.34 +5.73%
on 04/21/17
14.21 -15.62%
on 03/29/17
-2.24 (-15.74%)
since 03/28/17
3-Month
11.34 +5.73%
on 04/21/17
18.40 -34.84%
on 02/03/17
-5.97 (-33.24%)
since 01/27/17
52-Week
11.34 +5.73%
on 04/21/17
27.02 -55.63%
on 09/30/16
-6.24 (-34.23%)
since 04/28/16

Most Recent Stories

More News
Shares of DEPO Down 45.6% Since Downtrend Call on Shares

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 28th, 2016 at $22.73. In approximately 6 months, Depomed has returned 45.62% as of today's recent price of $12.36.

DEPO : 11.99 (-1.32%)
Depomed Announces Appointment of Sharon D. Larkin as Senior Vice President, Human Resources and Administration

Depomed, Inc. (NASDAQ:DEPO) today announced that Sharon D. Larkin joined Depomed as Senior Vice President, Human Resources and Administration.

DEPO : 11.99 (-1.32%)
Depomed Down 44.3% Since SmarTrend Downtrend Call (DEPO)

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 28th, 2016 at $22.73. In approximately 6 months, Depomed has returned 44.30% as of today's recent price of $12.66.

DEPO : 11.99 (-1.32%)
STRATA Skin Sciences and Depomed Recover from Wednesday's FDA Opioid Shockwave

NEW YORK, NY / ACCESSWIRE / April 10, 2017 / FDA Commissioner Scott Gottlieb sent a message to opioid manufacturers that he considers the abuse of opioids to be a crisis and a "public health emergency...

SSKN : 2.92 (-5.19%)
DEPO : 11.99 (-1.32%)
SmarTrend Watching for Potential Pullback in Shares of Depomed After 10.76% Gain

Depomed (NASDAQ:DEPO) traded in a range yesterday that spanned from a low of $12.10 to a high of $13.45. Yesterday, the shares gained 10.8%, which took the trading range above the 3-day high of $12.84...

DEPO : 11.99 (-1.32%)
Depomed Has Returned 45.2% Since SmarTrend Recommendation (DEPO)

SmarTrend identified a Downtrend for Depomed (NASDAQ:DEPO) on October 28th, 2016 at $22.73. In approximately 5 months, Depomed has returned 45.19% as of today's recent price of $12.46.

DEPO : 11.99 (-1.32%)
Depomed Announces Prepayment of $100 Million of Secured Debt Facility

- Company Intends to Refinance the Remainder of Secured Debt in 2017 -

DEPO : 11.99 (-1.32%)
Watch for Depomed to Potentially Rebound After Falling 3.94% Yesterday

Depomed (NASDAQ:DEPO) traded in a range yesterday that spanned from a low of $13.51 to a high of $14.21. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $14.13 on...

DEPO : 11.99 (-1.32%)
Darden Restaurants and Red Hat climb; McCormick skids

NEW YORK (AP) — Stocks that moved substantially or traded heavily Tuesday:

GM : 34.64 (+0.29%)
DRI : 85.19 (-0.90%)
PXD : 172.99 (+0.37%)
CCL : 61.77 (+1.30%)
RHT : 88.08 (-0.08%)
DEPO : 11.99 (-1.32%)
Depomed Announces Cooperation Agreement with Starboard Value LP Including CEO and Board Changes

-Pharmaceutical Veteran Arthur J. Higgins Joins as President, CEO and Director-

DEPO : 11.99 (-1.32%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Depomed, Inc. is a specialty pharmaceutical company utilizing its innovative AcuForm drug delivery technology to develop novel oral products and improved, extended release formulations of existing oral drugs. AcuForm-based products are designed to provide once- daily administration and reduced side effects,...

See More

Support & Resistance

2nd Resistance Point 12.53
1st Resistance Point 12.26
Last Price 11.99
1st Support Level 11.80
2nd Support Level 11.61

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.